carcinoma, transitional cell
Showing 1 - 24 of 24
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),
Active, not recruiting
- Carcinoma, Transitional Cell
- +6 more
- enfortumab vedotin (EV)
- +4 more
-
Anchorage, Alaska
- +105 more
Dec 19, 2022
Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, NSCLC Trial in Worldwide (Ramucirumab, Pembrolizumab)
Completed
- Gastric Adenocarcinoma
- +4 more
-
New Haven, Connecticut
- +21 more
Aug 17, 2022
Carcinoma, Transitional Cell Trial in Worldwide (Atezolizumab)
Terminated
- Carcinoma, Transitional Cell
-
Scottsdale, Arizona
- +185 more
Jun 13, 2022
Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)
Active, not recruiting
- Carcinoma, Transitional Cell
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 24, 2022
Carcinoma, Transitional Cell, HER-2 Gene Amplification Trial in Beijing (Trastuzumab)
Recruiting
- Carcinoma, Transitional Cell
- HER-2 Gene Amplification
-
Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Mar 31, 2022
Carcinoma, Transitional Cell Trial in Worldwide (Rogaratinib (BAY1163877), Chemotherapy)
Completed
- Carcinoma, Transitional Cell
- Rogaratinib (BAY1163877)
- Chemotherapy
-
Anchorage, Alaska
- +160 more
Feb 11, 2022
HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)
Recruiting
- HER2-positive
- +30 more
- CT-0508
-
Duarte, California
- +4 more
Feb 1, 2022
Carcinoma, Transitional Cell Trial in Beijing (nanoparticle albumin-bound paclitaxel, S-1, Gemcitabine, cisplatin)
Completed
- Carcinoma, Transitional Cell
- nanoparticle albumin-bound paclitaxel, S-1
- Gemcitabine, cisplatin
-
Beijing, ChinaChinese PLA General Hospital
Aug 5, 2021
Carcinoma, Transitional Cell Trial in Orange (Oxaliplatin with Gemcitabine)
Terminated
- Carcinoma, Transitional Cell
- Oxaliplatin with Gemcitabine
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Apr 9, 2021
Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis Trial in Israel, United States (UGN-101 instillations)
Completed
- Carcinoma, Transitional Cell
- Transitional Cell Carcinoma of Renal Pelvis
- UGN-101 instillations
-
Phoenix, Arizona
- +23 more
Dec 1, 2020
Carcinoma, Transitional Cell, Bladder Cancer, Bladder Tumor Trial in Worldwide (Pralatrexate Injection, Vitamin B12, Folic Acid)
Completed
- Carcinoma, Transitional Cell
- +2 more
- Pralatrexate Injection
- +2 more
-
Tucson, Arizona
- +18 more
Dec 10, 2019
Bladder Cancer, Carcinoma, Transitional Cell, Renal Pelvis Cancer Trial in Tampa, Minneapolis (Enzalutamide, Cisplatin,
Carcinoma, Transitional Cell Trial in Spain (Vinflunine, Undefined (standard care))
Completed
- Carcinoma, Transitional Cell
- Vinflunine
- Undefined (standard care)
-
Elda, Alicante, Spain
- +19 more
Apr 2, 2019
Breast Cancer, Ovarian Epithelial Cancer Recurrent, Sarcoma Trial in United States (Mifepristone and Eribulin in combination)
Completed
- Breast Cancer
- +6 more
- Mifepristone and Eribulin in combination
-
Tucson, Arizona
- +10 more
Jan 12, 2018
Cyr61 in Urinary Tract Transitional Cell Carcinoma
Unknown status
- Carcinoma, Transitional Cell
-
Banciao City, Taipei, TaiwanFar Eastern Memorial Hospital
Oct 5, 2010
Bladder Tumors, Ureteral Tumors, Urethral Tumors Trial in Baltimore, Cleveland, Seattle (TOCOSOL Paclitaxel)
Completed
- Bladder Neoplasms
- +3 more
- TOCOSOL Paclitaxel
-
Baltimore, Maryland
- +2 more
Jun 2, 2009
Carcinoma, Transitional Cell, Bladder Tumors Trial in Canada, United States (Oncolytic adenovirus (serotype 5) - CG0070)
Unknown status
- Carcinoma, Transitional Cell
- Bladder Neoplasms
- Oncolytic adenovirus (serotype 5) - CG0070
-
Phoenix, Arizona
- +9 more
Oct 1, 2008
Carcinoma, Transitional Cell Trial in Taipei (Lycopene)
Withdrawn
- Carcinoma, Transitional Cell
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 25, 2008
Bladder Tumors, Carcinoma, Transitional Cell Trial run by the NCI (suramin)
Completed
- Bladder Neoplasms
- Carcinoma, Transitional Cell
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
Urologic Tumors, Carcinoma, Transitional Cell Trial in Japan (Gemcitabine)
Completed
- Urologic Neoplasms
- Carcinoma, Transitional Cell
-
Fukuoka, Japan
- +11 more
Nov 5, 2007
Carcinoma, Transitional Cell Trial in Villejuif (gemcitabine, oxaliplatin)
Terminated
- Carcinoma, Transitional Cell
- gemcitabine, oxaliplatin
-
Villejuif, FranceInstitut Gustave Roussy
Aug 23, 2005